Golden Ally Lifetech Group, Inc.
AQPW
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.66% | 1,647.40% | -- | 15,088.46% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.74% | 1,786.28% | 1,493.82% | 15,143.27% | 4,230.68% |
| Operating Income | -23.74% | -1,786.28% | -1,493.82% | -15,143.27% | -4,230.68% |
| Income Before Tax | -23.74% | -1,786.28% | -- | -15,153.85% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.74% | -1,786.28% | -- | -15,153.85% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.74% | -1,786.28% | -1,493.82% | -15,153.85% | -4,230.68% |
| EBIT | -23.74% | -1,786.28% | -1,493.82% | -15,143.27% | -4,230.68% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -50.00% | -- | 95.35% | 60.00% | 91.30% |
| Normalized Basic EPS | -100.00% | -- | -- | 66.67% | -- |
| EPS Diluted | -50.00% | -- | 95.35% | 60.00% | 91.30% |
| Normalized Diluted EPS | -100.00% | -- | -- | 66.67% | -- |
| Average Basic Shares Outstanding | -12.82% | -54.08% | 41,171.55% | 38,448.05% | 91,084.90% |
| Average Diluted Shares Outstanding | -12.82% | -54.08% | 41,171.55% | 38,448.05% | 91,084.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |